Editor LSA

Stocks Under Consideration: United Continental Holdings Inc (NYSE:UAL), the Coca-Cola Company (NYSE:KO), Morgan Stanley (NYSE:MS), Abbott Laboratories

 

Lewes, DE -- (SBWIRE) -- 09/30/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: United Continental Holdings Inc (NYSE:UAL), The Coca-Cola Company (NYSE:KO), Morgan Stanley (NYSE:MS), Abbott Laboratories (NYSE:ABT).

United Continental Holdings Inc (NYSE:UAL), decreased -9.28% and closed at $30.91 on a traded volume of 12.76 million shares, in comparison to 4.98 million shares of average trading volume. So far this year, the stock is up over 32.21%.

The company has a total market capitalization of $11.00 Billion and its total outstanding shares are 355.90 million.

Has UAL Found The Bottom and Ready To Move Up? Find Out Here

United Continental Holdings, Inc. (UAL) is a holding company and its principal, wholly owned subsidiaries are United Air Lines, Inc. (United) and Continental Airlines, Inc. (Continental).

The Coca-Cola Company (NYSE:KO), plunged -0.88% and closed at $38.40 on a traded volume of 12.61 million shares, whereas its average trading volume is 14.68 million shares. In the last three months, the stock is up/down -4.26%. The Intra-day range for the stock is $38.15 and $38.58.

Will KO Get Buyers Even After The Recent Rally? Find Out Here

The Coca-Cola Company, incorporated on September 5, 1919, is a beverage company. The Company owns or licenses and markets more than 500 nonalcoholic beverage brands, primarily sparkling beverages but also a variety of still beverages, such as waters, enhanced waters, juices and juice drinks, ready-to-drink teas and coffees, and energy and sports drinks.

Morgan Stanley (NYSE:MS), dropped down -0.26% and closed at $27.08. So far in three months, the stock is up 10.85%. The 52-week range for the stock is $15.95 and $29.50 and during the previous trading session it marked$27.14 as its highest price. The stock initially exchanged hands with a price of $26.90 and the overall traded volume that day was 12.11 million shares.

Has MS Found The Bottom And Ready To Gain Momentum? Find Out Here

Morgan Stanley is a global financial services company that, through its subsidiaries and affiliates, provides its products and services to a range of clients and customers, including corporations, governments, financial institutions and individuals .

Abbott Laboratories (NYSE:ABT) after opening its shares at the price of $33.45, dropped -1.54% to close the day at $33.14. The stock ended on a traded volume of 11.82 million shares, in comparison to 7.66 million shares of average trading volume. The 52-week range for the stock is $31.64 and $72.47 and during the previous trading session the stock scored the highest price of $33.45. It started the day at $33.45.

Will ABT Get Buyers Even After The Recent Rally? Find Out Here

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products.

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/